Ocular Drug Delivery Solutions

  1. A/L/P Assembly, Label And Packaging 11/7/2025

    Integrated device assembly, labeling, and packaging solutions streamline pharma delivery, ensuring compliance, scalability, and patient-centric design from clinical trials to commercial production.

  2. Pharma Services Fill, Finish & Drug Delivery CDMO 11/7/2025

    Sterile fill-finish and device assembly capabilities span global sites, offering scalable solutions, analytical testing, and regulatory compliance for combination products and small-batch technical programs.

  3. NanoImprove The Performance Of Your Biologic Formulation 11/20/2025

    Unlock superior performance for peptides and proteins using nanotechnology. Achieve high drug loads for subcutaneous delivery and stable, aerodynamic dry powders for deep-lung inhalation.

  4. Innovative Formulations And Higher Drug Loads Across The Life-Cycle 11/20/2025

    Advanced particle engineering enhances the performance and life-cycle of therapeutics. Superior bioavailability, higher drug load, and improved stability are enabled for small and large molecules.

  5. Multiparticulates For Modified Release Systems 1/12/2026

    Multiparticulates enable tailored drug release with improved flexibility, dose accuracy, and patient convenience, leveraging technologies like Diffucaps® for customized profiles including immediate, delayed, extended, and pulsatile delivery.

  6. A Leading Drug Delivery CDMO 2/2/2026

    A look at integrated drug‑delivery expertise, scalable development paths, and advanced manufacturing that speed programs from formulation to global launch while reducing risk and improving efficiency.

  7. Bridgeton – Our World Class Fill Finish Facility 2/2/2026

    A scalable aseptic environment for diverse injectables, advanced automation, and Annex 1–aligned processes, supporting smooth transitions from development to commercial supply and long‑term strategy.

  8. A Comprehensive Approach That's Exceptional By Design 2/2/2026

    An overview of analytical capabilities to boost product quality, meet regulatory expectations, and drive development through phase‑appropriate methods and specialized testing for complex drug programs.

  9. Dermal Drug Delivery 2/2/2026

    A look at emerging dermal and intradermal delivery options, from customizable patches to microneedle systems, with key factors that enhance usability, stability, and therapeutic performance.

  10. Fast-Tracking Healthier Tomorrows For Patients And Our Planet 2/2/2026

    A focused look at how low‑GWP propellant technologies support sustainability goals while preserving inhaler performance, offering guidance for planning regulatory readiness, device compatibility, and long‑term respiratory portfolio strategy.